Network origin in Greg Whitehead first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Private Company | Biotechnology | 24 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Greg Whitehead via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Public Communications Contact | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| RADIUS HEALTH, INC. | Biotechnology | Director of Finance/CFO Investor Relations Contact | |
| NOVARTIS AG | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Masters Business Admin Doctorate Degree | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
| Temple University (Pennsylvania) | College/University | Undergraduate Degree | |
| Pepperdine University | College/University | Masters Business Admin | |
| Rensselaer Polytechnic Institute | College/University | Graduate Degree | |
| St. Bonaventure University | College/University | Graduate Degree | |
| University of North Texas | College/University | Undergraduate Degree | |
| Bogazici University | College/University | Undergraduate Degree | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
| King's College London | College/University | Graduate Degree | |
| Universidad Técnica Federico Santa María | College/University | Undergraduate Degree | |
The American Society of Transplantation
 The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services The American Society of Transplantation (AST) is a non-profit organization founded in 1982 that aims to advance the field of transplantation and improve patient care through research, education, advocacy, organ donation, and community service. The non-profit company is based in Mount Laurel, NJ. With over 4,000 professional members, AST is the largest transplant organization in the United States and is recognized as the premier society for transplantation. The society is sought out by other transplant organizations, policy makers, regulatory agencies, payors, academic institutions, and the general public for guidance, research, and resources related to transplantation. | Miscellaneous Commercial Services | President | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Cxloyalty Inernational Ltd.
 Cxloyalty Inernational Ltd. Miscellaneous Commercial ServicesCommercial Services Cxloyalty Inernational Ltd. provides marketing services to financial institutions and insurance companies. It offers sentinel card protection, a software protection, fraud insurance product for personal computer users, protection, insurance, travel, leisure products and services. The company was founded in 1971 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services | General Counsel | |
| Tibotec Pharmaceuticals | Chief Executive Officer | ||
Immune Tolerance Network
 Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Immune Tolerance Network provides clinical research services. It offers immune tolerance therapies for autoimmune disease, allergies and asthma, organ transplantation, and type 1 diabetes. The company was founded by Jeffrey A. Bluestone in 1999 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| UNIQURE N.V. | Biotechnology | General Counsel | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director of Finance/CFO | |
| Columbia Business School | College/University | Masters Business Admin | |
| The Curtis L. Carlson School of Management | College/University | Masters Business Admin | |
Adare Pharma Solutions, Inc.
 Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Lally School of Management & Technology | College/University | Masters Business Admin | |
| INNOCOLL HOLDINGS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| SYNLOGIC, INC. | Biotechnology | General Counsel | |
Rheos Medicines, Inc.
 Rheos Medicines, Inc. BiotechnologyHealth Technology Rheos Medicines, Inc. operates as a biopharmaceutical firm. It develops novel medicines that modulate metabolic pathways in immune cells to treat disease. The company was founded by Erika Pearce, Edward Pearce, Laurence Turka, Richard Flavell, Ken Smith, and E. William St. Clair and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
| ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Chief Operating Officer Corporate Officer/Principal | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Cytoimmune Therapeutics, Inc.
 Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
| VIRACTA THERAPEUTICS, INC. | Biotechnology | Chairman | |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Verimmune, Inc.
 Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 36 |
| United Kingdom | 5 |
| Switzerland | 3 |
| Ireland | 3 |
| Denmark | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 16 |
| Commercial Services | 6 |
| Finance | 3 |
Operational
| Corporate Officer/Principal | 51 |
| Director/Board Member | 44 |
| Undergraduate Degree | 18 |
| Independent Dir/Board Member | 17 |
| President | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Roger Pomerantz | 30 |
| Anne Prener | 14 |
| Mark F. Boshar | 13 |
| Natalie Holles | 13 |
| Susanne Antonie Schaffert | 13 |
| Torben Nissen | 12 |
| Andrew Oh | 12 |
| Laurence Turka | 10 |
| Jose Carmona | 10 |
| Nathan Dowden | 9 |
| Maiken Keson-Brookes | 8 |
| Christina Coughlin | 7 |
| Dannielle Appelhans | 7 |
| Joanne M. Protano | 7 |
| Elhan Webb | 6 |
- Stock Market
- Insiders
- Greg Whitehead
- Company connections